Published Date: 02 Mar 2023
A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.
Read Full NewsAmong 117 patients, breath-hold ventilation did not improve strict diagnostic yield vs conventional (86.8% vs 92.2%) in robotic bronchoscopy.
An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.
Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
3.
Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer
4.
Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures
5.
Distribution of fat could influence cancer risk, study suggests
1.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
2.
Clinical Guidelines for Immune Effector Cell Therapy Monitoring
3.
Modern Techniques in Hematology Across Clinical Settings
4.
Community-Based Cancer Survivorship Support Systems
5.
Clinical Pharmacology of Erythropoiesis-Stimulating Pathway Modulators
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recognizing General Warning Signs of Cancer
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
4.
Current Scenario of Cancer- The Incidence of Cancer in Men
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation